Stockholders' Equity - Grants Outside of 2000 and 2017 Plans and Stockholder Rights Plan (Details) $ / shares in Units, $ in Thousands |
|
|
|
|
|
|
|
3 Months Ended |
12 Months Ended |
|
|
|
Oct. 27, 2017
USD ($)
$ / shares
|
Oct. 21, 2016
USD ($)
|
Oct. 18, 2016
$ / shares
shares
|
May 06, 2016
Vote
$ / shares
|
Apr. 22, 2016
USD ($)
|
Apr. 19, 2016
$ / shares
shares
|
Aug. 28, 2015
USD ($)
|
Mar. 31, 2018
USD ($)
$ / shares
shares
|
Mar. 31, 2018
USD ($)
$ / shares
shares
|
Mar. 31, 2017
USD ($)
$ / shares
shares
|
Oct. 26, 2017
$ / shares
shares
|
Aug. 31, 2017
$ / shares
|
| Stockholder Rights Plan |
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
$ 0.001
|
$ 0.001
|
$ 0.001
|
|
|
| At-the-market Offering Program and Underwritten Offering of Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from sale of the common stock, after deducting fees and other offering expenses (in dollars) | $ |
|
|
|
|
$ 13,100
|
|
|
$ 5,300
|
$ 11,900
|
|
|
|
| Common stock, par value (in dollars per share) | $ / shares |
$ 0.001
|
|
|
|
|
|
|
$ 0.001
|
$ 0.001
|
$ 0.001
|
|
|
| Reduction of warrants to purchase common stock (as a percent) |
19.00%
|
|
|
|
|
|
|
|
|
|
|
|
| Number of common stock shares available to accredited investors |
|
|
3,600,000
|
|
|
|
|
|
|
|
|
|
| Share price of common stock sold (in dollars per share) | $ / shares |
|
|
$ 1.20
|
|
|
|
|
|
|
|
|
|
| Loss on adjustment of exercise price | $ |
|
|
|
|
|
|
|
|
$ 741
|
$ 421
|
|
|
| Net proceeds from offering of common stock and warrants | $ |
|
$ 6,800
|
|
|
|
|
|
|
$ 13,581
|
$ 20,188
|
|
|
| Number of common stock shares available in public offering |
|
|
|
|
|
2,700,000
|
|
|
|
|
|
|
| Number of warrants or shares of common stock to be sold to purchase common stock |
|
|
|
|
|
2
|
|
|
|
|
|
|
| Common stock sold (in shares) |
|
|
|
|
|
|
|
6,700,000
|
16,000,000
|
|
|
|
| Common stock commissions paid | $ |
|
|
|
|
|
|
|
$ 200
|
$ 300
|
|
|
|
| Total shares of common stock sold pursuant to the at-the-market offering program |
|
|
|
|
|
|
|
23,300,000
|
23,300,000
|
|
|
|
| Total net proceeds from sale of common stock | $ |
|
|
|
|
|
|
|
$ 24,600
|
$ 24,600
|
|
|
|
| Total common stock commissions paid | $ |
|
|
|
|
|
|
|
700
|
700
|
|
|
|
| Common stock available for issuance | $ |
|
|
|
|
|
|
|
$ 4,100
|
4,100
|
|
|
|
| Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
| At-the-market Offering Program and Underwritten Offering of Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares of common stock that could be purchased with warrants |
|
|
|
|
|
4,100,000
|
|
|
|
|
1,928,750
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
1.34
|
|
|
$ 3.50
|
|
|
|
|
$ 0.90
|
$ 0.60
|
| Net proceeds from sale of the common stock, after deducting fees and other offering expenses (in dollars) | $ |
$ 1,700
|
|
|
|
|
|
|
|
|
|
|
|
| Loss on adjustment of exercise price | $ |
|
|
|
|
|
|
|
|
$ 700
|
|
|
|
| Number of warrants or shares of common stock to be sold to purchase common stock |
|
|
|
|
|
1
|
|
|
|
|
|
|
| Number of shares of common stock purchased with each warrant |
|
|
|
|
|
1
|
|
|
|
|
|
|
| Length of time from issue date until warrants are exercisable |
|
|
|
|
|
6 months
|
|
|
|
|
|
|
| Length of time from exercise date until warrants expire |
|
|
|
|
|
5 years
|
|
|
|
|
|
|
| Outstanding warrants (in shares) |
|
|
|
|
|
|
|
8,478,750
|
8,478,750
|
|
|
|
| Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
| At-the-market Offering Program and Underwritten Offering of Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares of common stock that could be purchased with warrants |
|
|
|
|
|
5,500,000
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
1.20
|
|
|
$ 3.48
|
|
|
|
|
|
|
| Exercise price pre-funded at closing (in dollars per share) | $ / shares |
|
|
1.19
|
|
|
|
|
|
|
|
|
|
| Exercise price, payable upon exercise (in dollars per share) | $ / shares |
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
| Number of warrants or shares of common stock to be sold to purchase common stock |
|
|
|
|
|
2
|
|
|
|
|
|
|
| Number of shares of common stock purchased with each warrant |
|
|
|
|
|
1
|
|
|
|
|
|
|
| Length of time from exercise date until warrants expire |
|
|
|
|
|
9 months
|
|
|
|
|
|
|
| Outstanding warrants (in shares) |
|
|
|
|
|
|
|
0
|
0
|
|
|
|
| Minimum | Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
| At-the-market Offering Program and Underwritten Offering of Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares of common stock that could be purchased with warrants |
|
|
2,700,000
|
|
|
|
|
|
|
|
|
|
| Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
| At-the-market Offering Program and Underwritten Offering of Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate offering price for at-the-market offering program | $ |
|
|
|
|
|
|
$ 30,000
|
|
|
|
|
|
| Maximum | Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
| At-the-market Offering Program and Underwritten Offering of Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares of common stock that could be purchased with warrants |
|
|
6,300,000
|
|
|
|
|
|
|
|
|
|
| Stock options |
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Options outstanding (in shares) |
|
|
|
|
|
|
|
212,392
|
212,392
|
314,537
|
|
|
| Portion vesting one year after the issuance date (as a percent) |
|
|
|
|
|
|
|
|
25.00%
|
|
|
|
| Portion vesting on first day of each month after one year from the issuance date (as a percent) |
|
|
|
|
|
|
|
|
2.083%
|
|
|
|
| Expiration Term |
|
|
|
|
|
|
|
|
10 years
|
|
|
|
| Vesting period |
|
|
|
|
|
|
|
|
4 years
|
|
|
|
| Stock options | Grants outside of 2000 and 2017 Plans |
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Options outstanding (in shares) |
|
|
|
|
|
|
|
|
|
88,930
|
|
|
| Portion vesting one year after the issuance date (as a percent) |
|
|
|
|
|
|
|
|
25.00%
|
|
|
|
| Portion vesting on first day of each month after one year from the issuance date (as a percent) |
|
|
|
|
|
|
|
|
2.083%
|
|
|
|
| Expiration Term |
|
|
|
|
|
|
|
|
10 years
|
|
|
|
| Vesting period |
|
|
|
|
|
|
|
|
4 years
|
|
|
|
| Restricted stock units |
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock units outstanding (in shares) |
|
|
|
|
|
|
|
2,011,611
|
2,011,611
|
316,709
|
|
|
| Restricted stock units | Grants outside of 2000 and 2017 Plans |
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock units outstanding (in shares) |
|
|
|
|
|
|
|
|
|
14,820
|
|
|
| Series B Junior Participating Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder Rights Plan |
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred share purchase right ratio |
|
|
|
1
|
|
|
|
|
|
|
|
|
| Preferred stock conversion basis |
|
|
|
0.001
|
|
|
|
|
|
|
|
|
| Preferred stock, par value (in dollars per share) | $ / shares |
|
|
|
$ 0.001
|
|
|
|
|
|
|
|
|
| Purchase price (in dollars per share) | $ / shares |
|
|
|
$ 8.76
|
|
|
|
|
|
|
|
|
| Period following public announcement of beneficial ownership acquired by various persons resulting in rights becoming exercisable |
|
|
|
10 days
|
|
|
|
|
|
|
|
|
| Period following commencement of tender offer or exchange offer that would result in acquisition of beneficial ownership various persons resulting in rights becoming exercisable |
|
|
|
10 days
|
|
|
|
|
|
|
|
|
| Preferred stock dividend minimum if declared | $ / shares |
|
|
|
$ 1.00
|
|
|
|
|
|
|
|
|
| Preferred stock rights ratio over common stock |
|
|
|
1,000
|
|
|
|
|
|
|
|
|
| Number of votes per share | Vote |
|
|
|
1,000
|
|
|
|
|
|
|
|
|
| Ratio of consideration received in event of conversion or exchange transaction |
|
|
|
1,000
|
|
|
|
|
|
|
|
|
| Series B Junior Participating Preferred Stock | Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
| Stockholder Rights Plan |
|
|
|
|
|
|
|
|
|
|
|
|
| Beneficial ownership of common stock (as a percent) |
|
|
|
4.99%
|
|
|
|
|
|
|
|
|